home / stock / rlyb / rlyb short
Short Information | Rallybio Corporation (NASDAQ:RLYB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 905,774 |
Total Actual Volume | 7,527,471 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 45,289 |
Average Short Percentage | 20.36% |
Is there a RLYB Short Squeeze or Breakout about to happen?
See the RLYB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $1.39 | $1.2 | $1.42 | $1.155 | 714,816 | 120,942 | 16.92% |
07-01-2024 | $1.38 | $1.36 | $1.42 | $1.36 | 203,291 | 19,399 | 9.54% |
06-28-2024 | $1.5 | $1.34 | $1.5 | $1.34 | 3,550,136 | 115,451 | 3.25% |
06-27-2024 | $1.42 | $1.48 | $1.5 | $1.39 | 230,702 | 73,507 | 31.86% |
06-26-2024 | $1.49 | $1.4 | $1.53 | $1.4 | 215,823 | 40,757 | 18.88% |
06-25-2024 | $1.52 | $1.49 | $1.55 | $1.42 | 280,410 | 39,147 | 13.96% |
06-24-2024 | $1.48 | $1.54 | $1.6 | $1.45 | 177,882 | 28,857 | 16.22% |
06-21-2024 | $1.43 | $1.46 | $1.5 | $1.43 | 375,522 | 52,216 | 13.9% |
06-20-2024 | $1.4 | $1.44 | $1.4705 | $1.4 | 161,641 | 34,477 | 21.33% |
06-18-2024 | $1.45 | $1.4 | $1.475 | $1.395 | 174,318 | 37,175 | 21.33% |
06-17-2024 | $1.54 | $1.45 | $1.565 | $1.44 | 198,873 | 63,869 | 32.12% |
06-14-2024 | $1.62 | $1.545 | $1.66 | $1.48 | 133,564 | 41,854 | 31.34% |
06-13-2024 | $1.64 | $1.66 | $1.68 | $1.6 | 93,828 | 23,353 | 24.89% |
06-12-2024 | $1.6 | $1.65 | $1.7291 | $1.6 | 180,950 | 31,962 | 17.66% |
06-11-2024 | $1.49 | $1.64 | $1.64 | $1.49 | 154,174 | 25,155 | 16.32% |
06-10-2024 | $1.45 | $1.525 | $1.55 | $1.44 | 148,681 | 21,332 | 14.35% |
06-07-2024 | $1.52 | $1.48 | $1.54 | $1.46 | 115,165 | 32,210 | 27.97% |
06-06-2024 | $1.57 | $1.49 | $1.6 | $1.49 | 149,948 | 33,147 | 22.11% |
06-05-2024 | $1.55 | $1.61 | $1.62 | $1.51 | 137,893 | 30,248 | 21.94% |
06-04-2024 | $1.54 | $1.54 | $1.6 | $1.53 | 129,854 | 40,716 | 31.36% |
News, Short Squeeze, Breakout and More Instantly...
– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk for FNAIT Annually and the RLYB212 Addressable Market – ...
- On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 2H 2024 - - $94.2 Million in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2024; Provides Runway into Mid-2026 - Rallybio Corporation (Nasdaq: RLYB), a...